Trial intelligence / Profile preview

Citrate vs Heparin Lock in Cuffed Tunneled Catheter

TCTR20230107004Phase 3Recruiting

Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University
Start
Jun 2023
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of trisodium citrate, heparin in end-stage kidney disease (ESKD), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Jun 2023; status: recruiting.

02

Drugs

trisodium citrateheparin
03

Conditions

end-stage kidney disease (ESKD)

Beyond the preview

Go deeper on TCTR20230107004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230107004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call